comparemela.com
Home
Live Updates
PDS Biotechnology Q1 Loss Widens : comparemela.com
PDS Biotechnology Q1 Loss Widens
PDS Biotechnology Corp. (PDSB), a clinical-stage immunotherapy company, Monday, reported a wider loss for the first quarter, particularly impacted by personnel, clinical studies, medical affairs, and manufacturing expenses.
Related Keywords
,
Thomson Reuters ,
Biotechnology Corp ,
Loss Widens In Q1 ,
Pds Biotechnology Corp ,
Linical Stage Immunotherapy Company ,
comparemela.com © 2020. All Rights Reserved.